tiprankstipranks
Advertisement

IQSI - ETF AI Analysis

Compare

Top Page

IQSI

IQ Candriam ESG International Equity ETF (IQSI)

Rating:67Neutral
Price Target:
IQSI, the IQ Candriam ESG International Equity ETF, has a solid overall rating driven mainly by high-quality global leaders like ASML, AstraZeneca, Novartis, and Toyota, which all show strong financial performance, healthy growth prospects, and generally supportive technical or valuation profiles. This strength is partly offset by holdings such as Commonwealth Bank of Australia and Schneider Electric, where bearish momentum, higher leverage or cash flow concerns, and relatively expensive valuations weigh on the fund. The main risk factor is its meaningful exposure to a handful of large international names, so weakness in these key stocks or their regions could have an outsized impact on the ETF.
Positive Factors
Solid Recent Performance
The ETF has shown steady gains over the past month, three months, and year-to-date, indicating positive recent momentum.
Broad International Diversification
Holdings spread across many countries, with meaningful exposure to Japan, the UK, Switzerland, Australia, and others, help reduce reliance on any single market.
Low Expense Ratio
The fund’s relatively low fee means less of your return is eaten up by costs compared with many actively managed products.
Negative Factors
Country Concentration in Japan
A large portion of the portfolio is invested in Japanese stocks, which can increase the impact of economic or market issues specific to Japan.
Mixed Performance Among Top Holdings
While some leading positions like ASML and Toyota have performed strongly, several other top holdings have been weak, which can drag on overall returns.
Sector Tilt Toward Financials and Industrials
Heavy exposure to financial and industrial companies may make the ETF more sensitive to economic cycles and interest-rate changes.

IQSI vs. SPDR S&P 500 ETF (SPY)

IQSI Summary

IQ Candriam ESG International Equity ETF (IQSI) is a fund that tracks the IQ Candriam ESG International Equity Index, focusing on stocks from many countries outside the U.S. It invests in companies that meet environmental, social, and governance (ESG) standards, aiming to back businesses that act responsibly. The fund holds well-known names like Toyota, Nestlé, ASML, and Novartis, and spreads your money across many sectors and countries for diversification and long-term growth potential. A key risk is that international stock prices can go up and down with global markets and currency moves.
How much will it cost me?The IQ Candriam ESG International Equity ETF (IQSI) has an expense ratio of 0.15%, which means you’ll pay $1.50 per year for every $1,000 invested. This is lower than average for ETFs because it is passively managed, tracking an index rather than relying on active management.
What would affect this ETF?The IQ Candriam ESG International Equity ETF could benefit from growing global interest in ESG investing, as more individuals and institutions prioritize sustainability and ethical practices. However, its exposure to developed markets and sectors like Financials and Industrials may face challenges if economic growth slows or interest rates rise, which could impact corporate profitability. Additionally, regulatory changes or geopolitical tensions in key regions could create uncertainty for some of its top holdings.

IQSI Top 10 Holdings

IQSI’s story is all about high-quality international leaders with an ESG tilt, but recent performance has been a bit of a mixed bag. ASML has been a key engine for longer-term gains, even if it’s catching its breath lately. Health care heavyweights like Novartis and AstraZeneca are steady hands, while Roche has been more of a drag. On the defensive side, Nestlé has lost some fizz, and SAP and Siemens have been clear laggards. Overall, the fund leans toward developed Europe, with broad sector exposure rather than a single big-tech bet.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ASML Holding NV4.16%$9.76M€471.67B119.99%
76
Outperform
AstraZeneca2.25%$5.29M$318.08B52.48%
80
Outperform
Novartis AG2.11%$4.94MCHF223.05B44.23%
80
Outperform
Roche Holding AG2.00%$4.70M$320.22B29.20%
73
Outperform
Nestlé SA1.85%$4.33MCHF199.66B-2.32%
71
Outperform
Commonwealth Bank of Australia1.58%$3.70MAU$305.15B18.00%
64
Neutral
Toyota Motor1.57%$3.68M¥43.41T30.99%
80
Outperform
Siemens1.47%$3.45M€172.84B29.67%
74
Outperform
Schneider Electric1.20%$2.82M€144.24B28.05%
62
Neutral
SAP SE1.19%$2.79M€162.87B-37.25%
66
Neutral

IQSI Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
36.67
Positive
100DMA
35.84
Positive
200DMA
34.61
Positive
Market Momentum
MACD
0.07
Negative
RSI
61.06
Neutral
STOCH
95.03
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IQSI, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 35.45, equal to the 50-day MA of 36.67, and equal to the 200-day MA of 34.61, indicating a bullish trend. The MACD of 0.07 indicates Negative momentum. The RSI at 61.06 is Neutral, neither overbought nor oversold. The STOCH value of 95.03 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IQSI.

IQSI Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$237.38M0.15%
67
Neutral
$7.72B0.24%
72
Outperform
$1.55B0.15%
71
Outperform
$619.74M0.30%
64
Neutral
$219.72M0.50%
71
Outperform
$180.03M0.30%
71
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IQSI
IQ Candriam ESG International Equity ETF
37.19
8.64
30.26%
URTH
iShares MSCI World ETF
GSWO
Goldman Sachs ActiveBeta World Equity ETF
WSML
iShares MSCI World Small-Cap ETF
GDIV
Harbor Dividend Growth Leaders ETF
QWLD
SPDR MSCI World StrategicFactors ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement